guidovir.bsky.social
Group Leader at the University of Milan🇮🇹 Interested in #viral replication factories and Targeted Protein Degradation #TPD 🧬🦠🔬Previous MRC-LMB @mrclmb.bsky.social🇬🇧, University of Cambridge @uniofcam.bsky.social🇬🇧 and ICGEB-Trieste🇮🇹
👤 Joined on 17 November 2024
Followers
Following
Total Posts
@guipap.bsky.social@guipap.bsky.social → @papalab.bsky.social@papalab.bsky.social → @guidovir.bsky.socialSAVE THE DATE: Ubiquitin & Friends Symposium 2026 on April 29-30 or even better, sign up now: lnkd.in/eEQmaCYT It takes place at Van Swieten Hall, 1090 Vienna & is organized by the SFB Targeted Protein Degradation (incl. numerous research groups at Vienna BioCenter) @sfb-tpd-vienna.bsky.social
Show PostFantastic teamwork by Irene Schwartz & Valentina Budroni from the lab of @versteegga.bsky.social @maxperutzlabs.ac.at together with colleagues in our SFB consortium & beyond 👏Great to see the story out @natcomms.nature.com 🔗 www.nature.com/articles/s41...
Show PostOur paper is out in @natcomms.nature.com! APOBEC3s drive mutagenesis in cancer. We uncover a novel pathway keeping them in check. The key is APOBEC3 binding of cellular RNAs, which simultaneously controls their nuclear localization and shields them from degradation. Read it here: rdcu.be/e4qaa
Show Post#PressRelease🗞️ A specific molecular mechanism has been identified as the cause of the most frequent genetic forms of amyotrophic lateral sclerosis (ALS, also known as Charcot’s disease) and frontotemporal dementia (FTD). 👉 www.cnrs.fr/en/press/discov...
Show Post🚀 Introducing the "HT Seminars: Connecting Discoveries"! A new series bringing leading international researchers to Milan to explore what’s next in life sciences. Across disciplines, perspectives and technologies. Calendar & Registrations 👉 humantechnopole.it/en/training/... #HTseminars
Show Post